Resonetics has completed the acquisition of Resolution Medical, strengthening its ability to provide integrated, end-to-end device solutions for the interventional, structural heart, and neuromodulation markets.

The acquisition grows Resonetics’ design, finished device, and sub-assembly capabilities. Incorporating Resolution Medical’s biosimulation, design, new product introduction (NPI), and cleanroom assembly expertise with Resonetics’ AGILE Product Development group, precision component manufacturing, advanced materials, and battery technologies creates a more seamless platform to help OEMs reduce complexity, improve execution, and bring innovative devices to market more quickly.

“This marks an important milestone in Resonetics’ growth strategy,” said Kevin Kelly, CEO of Resonetics. “As device complexity increases, our customers are looking for partners who can take greater ownership across development and manufacturing. Bringing Resolution Medical into the Resonetics platform strengthens our ability to execute integrated programs at scale and support the next generation of innovative therapies.”

The combination bolsters the company’s ability to support neuromodulation, where coordination across device design, electronics, batteries, and assembly is crucial.

“Joining Resonetics allows us to amplify what we do best,” said Peter Herman, CEO of Resolution Medical. “Our team has built a strong reputation for solving complex engineering challenges. Now, as part of Resonetics, we can extend that impact by leveraging broader manufacturing depth, integrated component content, global resources, and expanded technical capabilities while continuing to deliver the responsiveness and expertise our customers expect.”

The deal builds on the company’s recent investments in battery, lead, and implantable and external pulse generator (IPG/EPG) manufacturing.